New data support palmitoylethanolamide’s efficacy against normal-tension glaucoma (NTG)

In the paper:

Effect of Palmitoylethanolamide on Visual Field Damage Progression in Normal Tension Glaucoma Patients: Results of an Open-Label Six-Month Follow-Up.

Italian ophtalmologists demonstrate the safety and efficacy of PEA in the treatment of normal-tension glaucoma (NTG). PEA was given to 16 patients suffering from NTG and 16 patients received no treatment. AT the end of 6 months the intraocular pressure was significantly reduced by PEA compared to the control group:

At six months, group A patients showed significant IOP reduction (from 14.4±3.2 mm Hg to 11.1±4.3 mm Hg, p<0.01) and moreover the visual fields improved significantly.

Source:
Costagliola C1, Romano MR, dell’Omo R, Russo A, Mastropasqua R, Semeraro F.. Effect of Palmitoylethanolamide on Visual Field Damage Progression in Normal Tension Glaucoma Patients: Results of an Open-Label Six-Month Follow-Up. J Med Food. 2014 May 14.

2 responses

  1. Theresia Hermann | Reply

    Where can I buy this product. I have glaucoma and want to reduce my intraoccular eye pressure, which this product apparently does.

    1. palmitoylethanolamide4pain | Reply

      http://www.peapure.com ships over the world

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: